Genprex is reprogramming the course of cancer and diabetes. Genprex’s CEO, Rodney Varner, will provi...
CEO and Chairman of the Board
Rodney Varner has served as CEO and chairman of the board for Genprex since August 2012. He has more than thirty-five years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company.